Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
16 to 26
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
2007_538
, V503-001, NCT00543543
2.
Phase I Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Positive and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
12 to 26
Sponsor:
NCI
Protocol IDs:
NCI-09-C-0024
, 09-C-0024, NCI-P07277, NCT00798265
3.
Pilot Study of the Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Virus-Like-Particle Recombinant Vaccine in HIV-Positive Women in India
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
AMC-054
, AMC-054, NCT00667563
4.
Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-Infected Men
Phase:
No phase specified
Type:
Diagnostic, Prevention
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
#33245
, NCT00666107
5.
Acceptance of Human Papillomavirus Vaccination in Postpartum Women
Phase:
No phase specified
Type:
Prevention
Status:
Approved-not yet active
Age:
18 to 26
Sponsor:
Other
Protocol IDs:
IRB-AAAD1877
, NCT00730704
6.
Alternate Dosing Schedules Study for HPV Vaccine
Phase:
No phase specified
Type:
Prevention
Status:
Active
Age:
9 to 15
Sponsor:
Other
Protocol IDs:
Pro00014388
, CDC#U36/CCU319276 CFDA 93.283, NCT00862810
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute